Literature DB >> 9128217

Coexistence of aldosteronoma and contralateral nonfunctioning adrenal adenoma in primary aldosteronism.

F Fallo1, L Barzon, M Boscaro, N Sonino.   

Abstract

A case of primary aldosteronism is presented in which computed tomography showed bilateral adrenal tumors. Adrenal scintigraphy during dexamethasone suppression revealed bilateral radiotracer uptake, with markedly predominant visualization of the left side. The left adrenal gland was removed, and an aldosterone-producing adenoma was confirmed by histologic examination. Fifteen months after surgery, serum potassium and plasma aldosterone were normal, and a marked decrease of blood pressure was observed, indicating that the right adrenal tumor was a benign nonfunctioning mass. Unilateral adrenalectomy on the side of the scintigraphically predominant lesion reversed the clinical syndrome of primary aldosteronism.

Entities:  

Mesh:

Year:  1997        PMID: 9128217     DOI: 10.1016/s0895-7061(96)00506-7

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

1.  Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas.

Authors:  Yah Yuen Tan; Jennifer B Ogilvie; Frederick Triponez; Nadine R Caron; Electron K Kebebew; Orlo H Clark; Quan-Yang Duh
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

Review 2.  A comprehensive review of the clinical aspects of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

Review 3.  Diagnosis and treatment of primary aldosteronism.

Authors:  Gian Paolo D Rossi
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

Review 4.  New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 4.592

Review 5.  Frequently asked questions and answers (if any) in patients with adrenal incidentaloma.

Authors:  F Ceccato; M Barbot; C Scaroni; M Boscaro
Journal:  J Endocrinol Invest       Date:  2021-06-23       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.